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Background: Caveolin-1 (Cav1) requires the caveolin scaffolding domain for caveola formation.
Results: The Cav1 scaffolding domain and oligomerization domain are tightly juxtaposed to the membrane in caveolae.
Conclusion:Concerted membrane association of the oligomerization, scaffolding, and intramembrane domains are critical for
caveola biogenesis and membrane deformation.
Significance: Understanding the membrane association of Cav1 is critical for dissecting how the protein regulates caveola
formation and achieves regulation over cellular signaling.
Thegenerationof caveolae involves insertionof the cholester-
ol-binding integral membrane protein caveolin-1 (Cav1) into
themembrane, however, the precise molecular mechanisms are
as yet unknown.We have speculated that insertion of the caveo-
lin scaffolding domain (CSD), a conserved amphipathic region
implicated in interactions with signaling proteins, is crucial for
caveola formation. We now define the core membrane-juxta-
posed region of Cav1 and show that the oligomerization domain
and CSD are protected by tight association with the membrane
in both mature mammalian caveolae and a model prokaryotic
system for caveola biogenesis. Cryoelectron tomography reveals
the coremembrane-juxtaposed domain to be sufficient tomain-
tain oligomerization as defined by polyhedral distortion of the
caveolar membrane. Through mutagenesis we demonstrate the
importance of themembrane association of the oligomerization
domain/CSD for defined caveola biogenesis and furthermore,
highlight the functional significance of the intramembrane
domain and the CSD for defined caveolin-inducedmembrane
deformation. Finally, we define the core structural domain of
Cav1, constituting only 66 amino acids and of great potential
to nanoengineering applications, which is required for caveo-
lin-induced vesicle formation in a bacterial system. These
results have significant implications for understanding the
role of Cav1 in caveola formation and in regulating cellular
signaling events.
Caveolae are small (50–80 nm in diameter) bulb-shaped
invaginations of the plasmamembrane (PM)4 that function in a
multitude of fundamental cellular processes, including the
mechanosensation response, cholesterol homeostasis, and the
regulation of cellular signaling (1–6). An essential structural
protein of caveolae is Caveolin-1 (Cav1) (7), a 22-kDa choles-
terol-bindingmembrane protein that has been hypothesized to
adopt a hairpin-like structure in the membrane, with both the
N and C termini facing the cellular cytoplasm (8).
The C terminus of Cav1 is composed of two separate
domains, the intramembrane domain (IMD, amino acids 102–
135) and the remaining residues (amino acids 136–178). It has
been hypothesized that the C terminus functions in lipid asso-
ciation as truncations consisting of this region in Cav1 and
Caveolin-3 (Cav3) were constitutively associated with intracel-
lular lipid droplets (9), and the C terminus is triply palmitoy-
lated during exportation from the Golgi. These post-transla-
tional modifications are not important for caveola formation
but have been shown to exert local effects on the insertion of
Cav3 within the membrane (10). Additionally, the C terminus
has been implicated in Cav1 homo-oligomerization as this
region can co-immunoprecipitate both the N and C termini of
the protein (11, 12). However, expression of a protein lacking
the final 31 amino acids of Cav1 (Cav1-(1–147)) resulted in
normal caveolar formation when expressed in Cav1/mouse
embryonic fibroblasts (13). The IMD is a highly hydrophobic
domain that is critical for caveolar formation (13, 14). NMR
spectroscopy and chemical shift indexing demonstrated resi-
dues 97–136 adopt a “horseshoe” structure within a micelle
membrane (15); residues 97–107 comprising -helix 1, sepa-
rated from -helix 2 (residues 111–129) by an unstructured
region (amino acids 108–110), and flanked by a second
unstructured region (residues 130–136). This horseshoe con-
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formation has been postulated to form a “wedge” between the
inner and outer leaflet of themembrane allowing formembrane
deformation, and is potentially responsible for the characteris-
tic caveolar morphology (15–17).
Structural analysis of the N terminus of Cav1 has remained
elusive, with conflicting reports suggesting both -helical (16,
18–21) and -sheet (22, 23) organizations. The N terminus
encompasses amino acids 1–101 and is commonly represented
with three separable domains comprising the membrane-asso-
ciated caveolin scaffolding domain (CSD, residues 81–101) and
the oligomerization domain (OD, amino acids 61–101) that
partially overlaps with the proposed N-terminal soluble do-
main (residues 1–80) (24). In cell systems,de novo expression of
Cav1 truncations demonstrated the deletion of the first 48
amino acids of the N terminus does not affect caveolar mor-
phology but further deletion of the next 11 amino acids abro-
gates caveola formation (13). The CSD is a critical domain for
caveolin oligomerization and caveola formation (13) but has
also been proposed to regulate cellular signaling events. The
interaction between the scaffolding domain and a consensus
sequence termed the caveolin bindingmotif (CBM, proposed to
have the sequence XXXXX, XXXXXX, or XXX-
XXXX where  is an aromatic residue and X is any amino
acid) has been hypothesized to regulate signaling via direct pro-
tein-protein-mediated sequestration of interacting proteins in
an inactive statewithin caveolae (2, 25–27).However, a number
of observations have questioned the likelihood of Cav1 regula-
ting signaling in this manner. Most critically, many of the
proposed CBMs appear unavailable for interaction with
caveolin, often comprising the highly hydrophobic core struc-
tural backbone of the proposed binding protein (28,29). Putat-
ive CBMs within proteins for which structural information is
available do not adopt specific structures and no particular
enrichment of CBMs has been observed in organisms with
caveolae compared with those without (28, 29). Finally, the
constitutive and irreversible association of signaling proteins
with the caveolin CSD does not explain how reversible intera-
ctions with signaling proteins can occur. The availability of the
CSD for interaction with CBMs has received less attention yet
remains another crucial aspect of the caveolin signaling
hypothesis.
Several studies have sought to ascribe both structural and
biochemical descriptions to homo-oligomerized Cav1, observ-
ing different sized oligomers of 200, 400, and 600 kDa (30) up to
3.3MDa (31) and different organizations, from filamentous and
ring-shaped (19) to ovoid complexes (30). Recently, it has been
demonstrated that the heterologous expression of Cav1 in
Escherichia coli resulted in the generation of caveola-like struc-
tures (32). It was demonstrated that heterologous caveolae
(h-caveolae) could be formed efficiently to high concentrations,
easily purified, and did not suffer from many of the drawbacks
of studying caveolin proteins inmammalian cell systems,muta-
tional analysis regularly results in exportation problems of the
Golgi complex (13, 33). h-Caveolae closely mimic the size of
mammalian caveolae, and possess similar numbers of Cav1
proteins andmutations in Cav1 that do not give rise to caveolae
in mammalian cells systems, similarly, did not form h-caveolae
(32). The intrinsic propensity for Cav1 to generate vesicles in a
heterologous system underlies the basic function of the protein
in the general cellular context. Cav1, likemany other proteins in
the mammalian cell, is involved in sculpting cellular mem-
branes although how this deformation is achieved remains
poorly understood (34).
In the current study we utilize this heterologous expression
system and purified mammalian caveolae to analyze the inser-
tion of Cav1 in the membrane, map the exact amino acids
tightly associatedwith themembrane, and analyze the effects of
deletions on h-caveola formation and structural regulation.We
define the minimal domain of Cav1 required for h-caveola for-
mation in bacteria and show that, remarkably, uniform vesicle
formation can occur upon the expression of less than 100
amino acids.
Experimental Procedures
Expression, Purification, and Cleavage of h-Caveolae—E. coli
(Rosetta pLysS DE3) were grown at 37 °C to an A600 nm of 1 in
Terrific Broth. Caveolin fusion protein constructs, under the
T7 RNA polymerase promoter, were induced with 1 mM iso-
propyl 1-thio--D-galactopyranoside (Astral Scientific) to
express for either 3 h (for EM) or overnight at 30 °C (for purifi-
cation). E. coliwere lysed using a Cell Disruptor (Constant Sys-
tems) and h-caveolae were purified using affinity chromatogra-
phy with amylose resin (New England Biolabs), eluted with
maltose (100 mM) in phosphate-buffered saline (150 mM NaCl,
15 mM K2HPO4/KH2PO4, pH 7.4), and concentrated with
100,000MWCOAmicon Ultracel Centifugal Filter (Millipore).
The MBP-CAV1-His6 fusion protein was engineered with two
tobacco etch virus protease cleavage sites between themaltose-
binding protein (MBP) and CAV1. Purified h-caveolae were
incubatedwithAcTEV (Invitrogen) at 4 °C overnight to remove
the MBP affinity tag.
Coomassie Staining and Western Blot Analysis—Purified
h-caveolae were boiled in Laemmli sample buffer (63 mM Tris-
HCl, pH 6.8, 0.2 M DTT, 2.5% SDS, and 1% bromphenol blue)
and proteins were separated using SDS-PAGE (15% acrylam-
ide). Gel staining was performed with Coomassie stain (0.25%
Coomassie Brilliant Blue R, 40% methanol, and 10% acetic acid
in water). Western blots were blocked in 5% milk powder dis-
solved in Tris-buffered saline with Tween (TBST, pH 7.4, 10
mM Tris-HCl, 150 mM NaCl, and 0.1% (v/v) Tween 20) and
incubated with various antibodies (MBP, New England Biolabs;
polyclonal caveolin, BD Transduction Labs, VIPN (30) and
Concav (45)) and visualized by chemiluminescence (Pierce).
Proteinase K Digestion—Purified h-caveolae were incubated
with ProK (20 g of ProK/mg of h-caveolae, New England
Biolabs) at 37 °C for 30 min.
Cloning—Site-directedmutagenesiswas performed to gener-
ate the N, C, and NC truncation mutants and the S80E,
F81E, and W85E point mutations. Primer sequences were as
follows: N-forward: GCTGATATCGGATCCATCGACCT-
GGTCAAC, N-reverse: GTTGACCAGGTCGATGGATCC-
GATATCAGC;C-forward, GTGCATCAGCCGTGTCATC-
GAAGGTCGTCATC, C-reverse: GATGACGCACTTCGA-
TGACACGGCTGATGCAC; S80E-forward: GAACCAGAA
GGAACACACGAGTTTGATGGCATCTGGAAG, S80E-
reverse: CTTCCAGATGCCATCAAACTCGTGTGTTCCT-
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TCTGGTTC, F81E-forward: CAGAAGGAACACACAGTG-
AAGATGGCATCTGGAAGG, F81E-reverse: CCTTCCAGA-
TGCCATCTTCACTGTGTGTTCCTTCTG, W85E-forward:
CAGTTTTGATGGCATCGAAAAGGCCAGCTTCACCAC,
W85E-reverse: GTGGTGAAGCTGGCCTTTTCGATGCCA-
TCAAAACTG, His6 removal-forward: GCAGAAAGAAA-
CAATCTAAGGTCGTCATCATC, His6 removal-reverse:
GATGATGACGACCTTAGATTGTTTCTTTCTGC.
Polymerase chain reaction was performed using HF Phusion
(New England Biolabs) DNA polymerase. The library of Cav1
truncations was designed in MacVector and sequences were
synthesized as gBlocks by Integrated DNA Technologies (IDT)
and inserted into a pNMTMA vector (as described previously
in Ref. 32) by cohesive-end cloning as per the manufacturer’s
instructions.
Purification of Caveolae—Madin-Darby canine kidney
(MDCK) cells stably expressing GFP or GFP-Cavin-1 were
scraped at 4 °C in TNE buffer (50mMTris-HCl, pH 7.4, 100mM
NaCl, and 0.1mM EDTA), syringe lysed, and spun at high speed
(100,000  g) in an ultracentifuge. The supernatant was dis-
carded and the pellet was resuspended in TNE buffer and incu-
bated with MBP-tagged GFP-trap. GFP/GFP-Cavin1GFP-trap
complex was bound to amylose resin (New England Biolabs) by
the MBP tag. The MBP-bound protein complex was washed
repeatedly with high salt PBS and GFP/GFP-Cavin-1 protein
was eluted with maltose and concentrated in 100,000 MWCO
Amicon Ultracel Centrifugal Filters (Millipore). ProK treat-
ment was performed as described previously, however, 0.5%
SDS for 30 min at 37 °C was utilized for detergent treatment as
caveolae are resistant to disruption by Triton X-100.
Preparation of Liposomes—E. coli extracted lipids (Avanti) in
chloroform (Sigma) were deposited on the sides of a round-
bottom flask by evaporating the organic solvent under a nitro-
gen atmosphere. To ensure the complete removal of chloro-
form, a formed lipid layer was stored overnight under vacuum.
Dried lipids were then hydrated with an aqueous buffer (20mM
HEPES-KOH, pH 7.5, 150 mM NaCl) at a concentration 1
mg/ml. To prepare 50-nm liposomes, a mini-extruder block
(Avanti) was heated to 65 °C. Liposomes were extruded 21
times through 50-nm polycarbonate filters (Avanti) and plunge
frozen immediately after preparation.
Mass Spectrometry—Protein bands were excised and
destained in 50% acetonitrile, 25 mM NH4HCO3, reduced with
20 mM dithiothreitol (DTT), alkylated with 50 mM iodoacet-
amide, adjusted to pH 8 with 50 mM NH4HCO3, dehydrated
with 100% acetonitrile, and dried with a SpeedVac. The dried
gel pieces were rehydrated and incubated overnight with 0.2g
of trypsin per gel band (in 10% acetonitrile, 50 mMNH4HCO3).
The digest was terminated with 5% formic acid and peptides
were extracted with a solution of 60% acetonitrile, 1% formic
acid. The extracted peptides were dried and resuspended in 5%
formic acid for mass spectrometric analysis.
Tryptic peptides were subjected to liquid chromatography-
tandem mass spectrometry using an Agilent 6520 QTOF cou-
pled with a Chip CUBE and 1200 HPLC. The nano pump flow
was set at 0.3 l/min and the capillary pump flow at 4 l/min.
TheHPLC-chip contained a 160-nl C18 trapping column, and a
150-mmC18 resolving column (AgilentG4240–62010). Buffer
Awas 0.1% formic acid andbuffer Bwas 0.1% formic acid in 90%
acetonitrile. The samples were analyzed with a 50-min LC gra-
dient, which increased from 5 to 50% Buffer B in 45 min,
increased up to 95% Buffer B in 1 min, was held at 95% Buffer B
for 3 min, and then was returned to 10% buffer B in 1 min. The
mass spectrometer was programmed to acquire 8 precursor
MS1 spectra and 4MS/MS spectra per second. Dynamic exclu-
sion was applied after 2 spectra and released within 0.25 min.
LC-MS/MS raw data generated was processed with Agilent’s
SpectrumMill. Datawere extractedwith carbamidomethylated
cysteine as fixedmodifications. The data were searched against
the speciesCanis familiaris of the SwissProt database, with car-
bamidomethylated cysteine as fixed modification, a maximum
missed cleavage of 2, precursor mass tolerance of 20, and
productmass tolerance of50. Results were filtered by protein
score of11.0, peptide score of10, and % Scored Peak Inten-
sity of60.
Electron Microscopy—Negative staining and immunolabel-
ing of purified h-caveolae, caveolae, and bacteria expressing
different caveolin truncations were performed as previously
described (32). Imaging was performed on a JEOL 1011 elec-
tron microscope at 80 kV fitted with a Morada 4K  4K soft
imaging camera (Olympus) with 2-fold binning.
Cryo-electron tomography (ET) was performed as described
previously (32). Images were recorded using LC-1100 Direct
Electron 4K 4K camera (at a binning of 2) under the control
of SerialEM (35). Tilt-series were reconstructed using 10-nm
fiducial markers and weighted back-projection in IMOD (36).
Cryo-tomograms were subjected to a mild de-noising, non-lin-
ear anisotropic diffusion filter, to improve the signal-to-noise
ratio (37).
Electron tomography was performed on E. coli preserved
by high-pressure freezing (EMPact2, Leica) and freeze sub-
stitution (AFS2, Leica) in 1% osmium tetroxide OsO4 and
0.1% UA then subjected to temperature ramping and cells
were embedded in epon. Thick sections (300 nm) were cut
on an ultramicrotome (UC6, Leica). Dual-axis tilt series were
acquired on a TECNAI F30 (FEI) electron microscope
encompassing a tilt range of 60 to 	60o at 2o increments.
Image acquisition was performed with a Direct Electron
LC-1100 4K  4K camera with 2-fold binning under the
control of SerialEM (35). Reconstructions were performed
using weighted back-projection in IMOD. Semi-automated
segmentation was employed (38, 39) to generate a three-
dimensional representation of h-caveolae. Morphometric
analysis of h-caveola diameters was performed as follows;
individual h-caveola were scanned through the “z” dimen-
sion to determine the central region and measured, outer-
membrane to outer-membrane, such that the bilayer was
spanned twice (excluding the protein coat). Two-tailed
Student’s t-test were performed to determine significance.
Results
Mapping the Membrane-protected Domains of Cav1—The
C-terminal domain (residues 102–178) and the CSD (residues
81–101) of Cav1 have been shown to possess membrane-bind-
ing affinity (11, 15, 40, 41) and have been predicted by multiple
different studies to adopt a predominantly -helical structure
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(14–16, 22, 42, 43). Despite these observations, the exact resi-
dues tightly associated with the membrane have remained
unclear. A summary of predicted and experimental structural
data includingmembrane-associated domains is represented in
Fig. 1. Using our model heterologous system and biochemical
approaches coupled with enzymatic degradation of the soluble
domains of Cav1, we investigated the exact residues tightly
associatedwith themembrane. For all subsequent experiments,
unless otherwise stated, MBP-Cav1-His6 h-caveolae (72 kDa,
the standard caveogenic fusion protein characterized previ-
ously (32)) were purified using theMBP tag then treated with a
tobacco etch virus protease to specifically cleave the MBP tag
from the membrane-associated Cav1-His6 (22–24 kDa).
Purified Cav1-His6 h-caveolae were treated with a nonspecific
protease, proteinase K (ProK), to degrade accessible Cav1
epitopes.
After ProK treatment several small molecular mass bands, of
16–17 and 11–14 kDa, can be observed by Coomassie stain-
ing (Fig. 2A). To determine whether these remaining small
molecular weight bandswereCav1 domains, liquid chromatog-
raphy tandemmass spectrometry (LCMS/MS) was performed
on the largest and most abundant fragment after ProK treat-
ment. Control bands (undigested) showed a high abundance of
tryptic peptides of Cav1 (Table 1) comprising amino acids 5 to
172, although the IMD (residues 102–136) was undetected.
This highly hydrophobic domain does not possess tryptic cleav-
age sites and therefore is likely to result in a peptide too large for
the detection by LCMS/MS analysis employed here. The undi-
gested bands after ProK treatmentwereCav1 peptides, but only
constituted 41.6% of the protein (Table 1). Mapping of these
domains revealed Cav1 lacked the immediate N-terminal
domain but highly abundant peptides comprising a complete
sequence from amino acids 48–102, as well as 135–148, were
observed (Table 1). Interestingly, residues from the C terminus
of Cav1, amino acids 165–172, were also highly abundant
(Table 1), suggesting that this peptide may be involved in lipid
interactions.
To confirm our proteomic analysis, the small molecular
weight bands were screened with a panel of antibodies directed
against different domains of Cav1. An -MBP antibody was
utilized as a control to assess the effectiveness of ProK treat-
ment, after which almost all reactivity was lost (Fig. 2B). The
protected fragment after ProK digestion lacked reactivity to the
VIP-N antibody (recognizes the first 20 amino acids of Cav1)
after ProK digestion suggesting the first 20 residues of Cav1 are
not tightly associated with the membrane and confirming our
proteomic analysis. However, reactivitywas observedwith both
the polyclonal -caveolin antibody (directed against multiple
recognition sites between amino acids 1–97) and the Concav
-caveolin antibody that recognizes a region within the OD
immediately adjacent to theCSD (amino acids 67–81) (Fig. 2B).
To determinewhether these domains are protected fromProK-
mediated digestion by their membrane association, we per-
formed ProK treatment before and after membrane disruption
with the non-ionic detergent Triton X-100. A complete degra-
dation of the protected small molecular weight fragments of
Cav1 was observed when ProK treatment was performed after
Triton X-100 treatment (Fig. 2C), which corresponded with a
complete disruption of h-caveola structure (Fig. 2D). Further-
more, immunoelectron microscopy (immuno-EM) of purified
h-caveolae demonstrated that the Concav epitope was unavail-
able for binding in fully formed h-caveolae unless pre-treated
with Triton X-100 (data not shown). These data suggest that
tight association with the membrane results in protection from
ProK-mediated digestion. The protected residues of Cav1 are
schematically represented in Fig. 2E, this analysis closely mim-
ics previous observations that demonstrated the minimal
caveogenic domain of Cav1 to encompass amino acids 49–147
(13).
The OD of Cav1 Is Protected from ProK Digestion in Mature
Mammalian Caveolae—To examine whether this model of
membrane insertion/association is consistent between h-cave-
olae and mature mammalian caveolae, caveolae were purified
from MDCK cells using a novel pull-down method (schematic
in Fig. 3A) exploiting stable expression of GFP-tagged Cavin-1,
a specific marker of PM caveolae (44). Previous observations
have demonstratedCav1 is present inmultiple different subcel-
lular domains and undergoes different conformational changes
FIGURE 1. Alignments of observed and predicted structural organizations for full-length caveolin 1 and peptides of Cav1. Red
 -helix, light blue

-sheet, and gray
 predicted transmembrane domain.
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during its maturation/export to the PM (8,45). Cav1 is also
present in non-caveolar pools at the PM suggesting Cav1 itself
is an unsuitable candidate for the immunoprecipitation of
mature PM caveolae (46). Cavin1, however, is exclusively local-
ized to caveolaewhen present at themembrane and therefore is
ideal for the isolation of mature PM caveolae (44). An 8-fold
enrichment of purified caveolin-positive vesicles was observed
comparing MDCK cells expressing Cavin1-GFP with cells
expressing GFP alone (Fig. 3, B–D). Purified mammalian cave-
olaewere subjected to ProK treatment, after which, the remain-
ing fragment of Cav1 demonstrated a shift in molecular mass
from23 to16–17 kDa, and demonstrated strong reactivity
to both the Concav and polyclonal-caveolin antibodies. Reac-
tivity to both the VIP-N epitope and the GFP tag from Cavin1
was completely lost after ProK treatment, indicating degrada-
tion was effective and confirming the first 20 amino acids of
FIGURE 2. Cav1 is protected from ProK digestion by tight association with the bilayer. A, Coomassie stain of purified MBP-Cav1-His6 h-caveolae ProK.
Small molecular mass bands of approximately 16–17 and 11–14 kDa remained. B, Western blot analysis of Cav1-His6 (after tobacco etch virus cleavage) using
the -MBP, VIP-N, polyclonal and Concav -caveolin antibodies. VIP-N recognizes amino acids 1–20, the polyclonal -caveolin has multiple recognition
domainsbetweenaminoacids1and97, and theConcavantibodybinds residues67–81.C, Coomassie stainofpurifiedCav1-His6h-caveolae (tobaccoetchvirus
cleaved) 0.5%TritonX-100 for 1 hprior to ProKdigestion. The smallmolecularweight fragments of Cav1 are lostwhenh-caveolae are disruptedprior to ProK
treatment.D, negative staining (1% uranyl acetate) of purified h-caveolae show ProK digestion does not disrupt h-caveola morphology, however, a complete
loss of morphology is evident in the Triton X-100-treated conditions. Scale bar, 100 nm. E, refined model of Cav1 association with the membrane.
Dissecting Caveolin-induced Curvature
OCTOBER 9, 2015•VOLUME 290•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 24879
 at UQ Library on July 18, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Cav1 are exposed for degradation (Fig. 3E). No reactivity to
Cav1 was observed in purified caveolae pre-treated with 0.5%
SDS for 30 min prior to ProK digestion (SDS was used as mam-
malian caveolae are resistant Triton X-100 disruption). Previ-
ous work has demonstrated the Concav -caveolin antibody is
only reactive against the intracellular pool of Cav1 in mamma-
lian cells and not against Cav1 at the PM unless pre-treated
with cholesterol perturbing agents (47). Together with our
data this indicates that the OD adjacent to CSD is tightly
associated with the membrane in both mature mammalian
caveolae and h-caveolae.
Membrane-associated Domains of Cav1 Are Sufficient for
Membrane Deformation—We have previously shown that for-
mation of h-caveolae in bacteria depends on caveolin oligomer-
ization and gives rise to the polyhedral tertiary structure of
h-caveolae (32). High-resolution cryo-ET revealed distinct
membrane organization, defined as clear angles in the mem-
brane through the medial plane of each h-caveola, and indicate
that caveolin oligomers (directly or indirectly) cause distortion
of the h-caveolar membrane (Fig. 4A). This is particularly evi-
dent in comparison to liposomes of similar bacterial lipid com-
position and size (Fig. 4C) that show a completely circular pro-
file through the medial plane. To test whether membrane
distortion was a feature of the membrane-associated domains
of Cav1 or were imposed on the membrane by interactions on
the exposed cytoplasmic face of h-caveola, h-caveolae treated
with ProKwere examined by cryo-ET. ProK-treated h-caveolae
showed similar membrane distortion when compared with the
control samples (Fig. 4B). Proteinase treatment resulted in a
reduction in the density of the h-caveola coat, likely the MBP
affinity tag, when compared with the control. These results
indicate that the proteolytically protected fragments of Cav1
are sufficient to maintain three-dimensional structural integ-
rity of h-caveolae.
The data obtained from our proteomic, biochemical, and
cryo-ET analyses indicated the importance of the central
domain of Cav1 for maintaining the three-dimensional struc-
ture of h-caveolae. Therefore, we generated a series of trunca-
tion mutants of the caveolin fusion protein: an N-terminal
truncation, N, (Cav1-(49–178)), a C-terminal truncation, C
(Cav1-(1–147)), and an N and C termini truncation, NC
(Cav1-(49–147)) (Fig. 4D) to analyze the function of these
domains in regulating the formation of h-caveolae. A time
course of the expression of the Cav1 truncations demonstrated
efficient and comparable protein expression after 3 h of induc-
tion (Fig. 4E). To further understand the role these domains
have in the oligomeric arrangement of Cav1, the ability of these
constructs to form h-caveolae was assessed using immuno-EM
of cryosections. The full-lengthMBP-Cav1-His6 construct gen-
erated h-caveolae (Fig. 4F) as previously described (32). Both
theN andNC constructs efficiently generated h-caveolae of
consistent size and shape (Fig. 4, G and I). The C truncation,
however, generated more pleomorphic structures with larger
diameters and with reduced efficiency of formation (Fig. 4H;
see also Fig. 5, C and E). It was confirmed by ProK-mediated
digestion that the NC truncation represents the core mem-
brane-associated domain by Western blot analysis, as ProK
degradation did not result in a reduction in the size of the
molecular weight of Cav1 (Fig. 4J).
ET was utilized on high-pressure frozen freeze-substituted
E. coli expressing the various truncations after 3 h of induction
to dissect changes in the three-dimensional architecture of
h-caveolae in response to the N- and C-terminal truncations.
Consistentwith our previous observations,CCav1h-caveolae
were significantly larger (average diameter of full-length
 39.3
nm (n 
 559) and C 
 43.3 nm (n 
 300)) and also demon-
strated greater variation in size (standard deviation of full-
length 
 11.4 nm compared with C truncation 
 13.0 nm)
than full-length Cav1 h-caveolae (Fig. 5, A, C, and E). The N
termini truncation mutants, however, demonstrated a signifi-
cant reduction in both the diameter, n 
 29.0 nm (n 
 545)
and NC 
 31.0 nm (n 
 356), and the degree of variation in
diameter (standard deviation of N h-caveolae 
 5.8 nm and
NC h-caveolae
 7.1 nm) (Fig. 5, B,D, and E). Through high-
resolution electron tomography-based approaches we have
determined that the deletion of the N terminus, whereas not
essential for h-caveola formation, results in a more monodis-
perse population of h-caveola diameters.
Dissecting the Membrane Association of the OD and CSD—
Our data suggest that theODandCSDare protected fromProK
enzymatic digestion by their tight association with the mem-
brane. To further examine the legitimacy of this claim we
mutated a single amino acid, Ser80, to a negatively charged glu-
tamate residue. Ser80 is located in the middle of the OD and
adjacent to the CSD, which is critical for lipid binding and
caveola and h-caveola structural integrity (13,32,48). As previ-
ously demonstrated, the introduction of this S80E point muta-
tion disrupted h-caveola formation with the full-length MBP-
Cav1-His6 fusion protein (Fig. 6A) (32). We confirmed this
result with the N, C, and NC truncations by immuno-EM
of cryosections; the S80E point mutant resulted in complete
loss of defined h-caveola formation and dramatic tubulation of
the cytoplasmic membrane (Fig. 6, B–D, respectively). Addi-
tionally, electron tomography and segmentation analysis dem-
onstrated an increased number of connectionsmaintainedwith
the cytoplasmic membrane (Fig. 6, E and F) when compared
TABLE 1
Summary of detected peptides after ProK treatment
Dissecting Caveolin-induced Curvature
24880 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 41•OCTOBER 9, 2015
 at UQ Library on July 18, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
with a non-mutated control (Fig. 6G) suggesting the introduc-
tion of the S80E point mutation results in a reduction in the
potential to perform fission from the bulk membrane. Further-
more, ET revealed a complete loss of defined h-caveola forma-
tion (average diameter N S80E 
 89.9 nm, standard devia-
tion 
 30.6 nm: average diameter C S80E 
 110.1 nm and
standard deviation 
 41.2 nm) (Fig. 6, H–J). These data are
consistent with a model whereby normal association of the OD
and CSD with the membrane is critical for defined h-caveola
formation and the addition of a single negatively charged resi-
FIGURE 3. The OD is protected by the PM in mature caveolae. A, schematic of the method used for mammalian PM caveolae purification, as described in
detail under “Experimental Procedures.” B, immunolabeling of GFP expressing MDCK cells shows very few caveolin positive vesicles (polyclonal -caveolin
primary, 10-nm Protein A Gold secondary). C, immunolabeling of immunoprecipitated vesicles fromMDCK cells expressing Cavin1-GFP demonstrated abun-
dant and specific labeling of vesicles within the size range of caveolae. D, quantification of Cav1-positive vesicles. E, purified caveolae from MDCK cells
expressing GFP-Cavin1 digested with ProK alone or treated with 0.5% SDS for 30 min at 37 °C prior to ProK digestion. Scale bars, 100 nm.
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due at Ser80 results in the forced separation between the
CSD/OD and membrane.
To confirm the importance of themembrane insertion of this
domain in defined h-caveola structure formation we generated
additional mutants; a N construct lacking the polyhistidine
tag and two additional point mutants in aromatic side chains of
theOD/CSD predicted to insert into the lipid bilayer,NPhe81
to glutamate (F81E) and N Trp85 to glutamate (W85E). The
N construct that lacked the polyhistidine tag generated mor-
phologically typical h-caveolae (Fig. 7A), confirming the poten-
tially charged residues that comprise the His-tag do not affect
formation. The two point mutants, however, resulted in a loss
of defined vesicular h-caveola structure (Fig. 7, B andC) resem-
bling the tubular invaginations generated by the N S80E
mutant (Fig. 6B).
To further test this hypothesis, we analyzed the effect and
extent of ProK degradation on theN construct in comparison
to N S80E, N F81E, and N W85E point mutants (the N
and N point mutants were used because these constructs
expressed equivalently). In agreement with our hypothesis, the
substitution of a glutamate residue at Ser80 resulted in almost
complete proteolytic degradation of Cav1 by Western blot
analysis of theOD/CSDwith theConcav antibody (Fig. 7D) and
a significant reduction in band intensity was observed compar-
ing the fold-changes of N S80E  ProK but not N  ProK
(Fig. 7E). The extrusion of N F81E and N W85E OD/CSD
domains were confirmed by Western blot as these domains
were largely digested by protease treatment (Fig. 7, D and E).
These results suggest that the disruption of the association/
insertion of theOD/CSDwith themembrane by the addition of
the S80E, F81E, orW85E point mutations is causal in the abro-
gating defined h-caveola structure (a schematic is represented
in Fig. 7F).
The IMD and CSD Are Critical for h-Caveola Formation—
Next we investigated the minimal required structural domains
for h-caveola formation. We generated an extensive library of
Cav1 truncations and analyzed the ability of these different
truncations to generate h-caveolae by immuno-EM of frozen
sections. For this assay we have defined the formation of mor-
phologically typical h-caveolae by the appearance of gold-la-
beled circular membranous profiles within the cytoplasm of
expressing E. coli, as shown in Fig. 4, F–I. This is indicative of
formation of the uniformly shaped spherical free vesicles typi-
cal of h-caveolae as shown by tomography (Fig. 5 and Ref. 32).
As both the IMD and CSD have previously been demonstrated
to be essential domains for caveolar formation (13, 14, 33) we
first interrogated the structural outcomes of deleting these
domains. The removal of the IMD (Cav1-(49–97,134–178))
completely abrogated h-caveola formation and membrane
association (Fig. 8A), whereas the removal of the CSD (Cav1-
(49–81,97–178)) resulted in the accumulation of bacterial
membranes in the cytoplasm of expressing cells but did not
result in a defined structure (Fig. 8B).
Maintaining the core structural domains for h-caveola for-
mation, we then performed sequential truncation of the C ter-
minus and defined two different phenotypes; the removal of 13
further residues from the core membrane-associated domain
(Cav1-(49–134)) caused a loss of defined h-caveolae structure
and extensive tubulation (Fig. 8C). However, the additional
removal of the IMD resulted in a completely soluble protein
(Cav1-(49–101), Cav1-(60–101), and Cav1-(81–97); Fig. 8,
D–F). Intriguingly, the further removal of the N terminus did
not significantly affect h-caveola formation as both Cav1-(60–
147) and Cav1-(81–147) retained the ability to generate mor-
phologically typical h-caveolae (Fig. 8, G and H), suggesting, in
our model prokaryotic system, the first 20 residues of the OD
are not critical for h-caveola formation. Finally, the truncation
of the remaining domains completely abrogated h-caveola
structure; the CSD and IMD (Cav1-(81–134)) alone were
unable to localize to membranes (Fig. 7I), whereas constructs
consisting of the IMD alone (Cav1-(97–147) and Cav1-(97–
134)) were localized to the cytoplasmic membrane but did not
bend the membrane (Fig. 8, J and K). These data suggest that
both the IMD and the CSD are essential for h-caveola structure
and for the first timewe define aminimal h-caveogenic domain,
a short sequence of only 66 amino acids (Cav1-(81–147)) that
can generate vesicles when expressed in E. coli.
Discussion
This study of caveolae produced in a model prokaryotic sys-
tem has facilitated novel insights into Cav1, how it associates
with the membrane, and the role different domains have in
regulating h-caveola formation and structure. Using a variety of
techniques, including negative staining electron microscopy,
electron tomography, biochemical approaches, mass spec-
trometry, cryosectioning, and immunolabeling and cryo-elec-
tron tomography, we have identified Cav1 peptides that are
protected from protease degradation and determined the core
structural domain required defined h-caveola formation. These
results have fundamental implications for understanding the
topology of Cav1 in the membrane and how Cav1 could regu-
late signaling events in the cell.
Cav1 has, to date, been represented as a protein with two
separable domains, the largely soluble N-terminal domain (11,
41) and the hydrophobic C terminus (12, 41). The results pre-
sented here indicate that a reassessment of these boundaries is
required. We have shown that the core membrane-associated
domain of Cav1 constitutes residues 49–147; close to the min-
imal domain for caveola formation in mammalian cells (13).
FIGURE 4.Membrane-associated domains of Cav1 are sufficient formembrane-deformation.A, optical slices through themedial plane ofMBP-Cav1-His6
h-caveolae, abundantprotein coat is observedaroundeachh-caveola. Scale bar
5nm.B,optical slices through themedial planeofMBP-Cav1-His6h-caveolae
	 ProK  no protein coat was observed to each h-caveola. Scale bar 
 5 nm. The medial planes of MBP-Cav1-His6 h-caveolae  ProK possess definitive
polyhedral tertiary structure as defined by the clear angled profile to the membrane. C, comparative medial plane slices through liposomes demonstrating
circular profiles. Scale bars
 5 nm.D,diagrammatic representation of Cav1 truncations generated for biochemical and structural analysis. E,Western blot time
course of induction (-MBP) of the Cav1 truncations. F, MBP-Cav1-His6 construct generated h-caveola consistent with previous observations(32). G, N
generated h-caveolae of regular size efficiently. H, C was less efficient in generating regular size and structurally uniform h-caveolae. I, NC generated
h-caveolae of regular size efficiently. Labeling for F–I, -MBP antibody primary (1:100 dilution) and 10-nm PAG secondary (1:70 dilution). Scale bars, 100 nm. J,
Western blot analysis with the Concav antibody demonstrates ProK treatment of NC does not reduce the molecular weight.
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To investigate the importance of the core membrane-associ-
ated domain in h-caveola structure formation we generated a
library of truncations and assayed h-caveola formation concur-
rently with the membrane attachment by immuno-EM. As
Cav1 is an integral membrane protein, the conservation of
membrane association is critical for elucidating domain
FIGURE 5. Three-dimensional characterization of h-caveolae generated by Cav1 truncations. A, an optical slice from a reconstructed tomogram of an
E. coli expressing full-length MBP-Cav1-His6 h-caveolae. B–D, optical slices of E. coli expressing N, C, and NC. Red asterisks highlight small h-caveolae. E,
distribution of the diameters of h-caveolae revealed significant changes in h-caveolae structure and size compared with the full-length protein. Significant
differences between themeans of populations are indicated by asterisks on the right comparing two populations and illustrating differenceswith p 0.01 (**)
and p  0.001 (***), respectively. Diameters were measured from the outer leaflet to the corresponding outer leaflet through the medial plane of each
h-caveola. IMODinfo was used to export diameter measurements from IMOD for two-tailed Student’s t-test statistical analyses. Scale bar, 50 nm.
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function but is often overlooked in biochemical assays of
caveolin oligomerization (11, 12). Our results demonstrated
that both the mutation of the CSD and the deletion of this
domain abrogated the defined vesicular structure, reiterat-
ing the importance of the CSD for caveola formation (13).
Additionally, we demonstrated the IMD is critical for
h-caveola formation. In our assays the IMD, in concert with
amino acids 135–147, mediated the retention of the protein
within the bacterial membrane; the removal of these
domains resulted in the association of Cav1 to the cytoplasm
of expressing cells. It is known that mutation of this region
abrogates caveola formation in mammalian cells and inhibits
the export of the protein from the Golgi complex to the PM
(13, 14, 33). Intriguingly, large regions of the N terminus
could be removed without affecting h-caveola formation, in
some cases resulting in a more regular structure. It is possi-
FIGURE 6.Mutating Ser80 abrogates defined h-caveolae formation. A–D, immunolabeled frozen sections of E. coli expressing Cav1S80E,N S80E,C S80E,
andNCS80E, respectively. Sectionswere labeledwith an-MBP antibody (1:100) and 10-nmProteinAgold (1:70). A loss of definedh-caveolae formation and
a marked increase in the number of tubules were observed. Scale bar, 100 nm. E, optical slice of reconstructed electron tomogram employed to analyze the
structure of h-caveolae generated by S80E point mutation in three dimensions. An increase in the number of cytoplasmic membrane connected h-caveolae
was observed. Black arrowheads indicate membrane-connected h-caveolae. Scale bar, 100 nm. F, segmentation of C S80E, abundant surface connected
h-caveolae (solid white) were observed when compared with h-caveolae where no connections were resolved (red). Cytoplasmic membrane, translucent
white. Scale bar, 100 nm. G, segmentation of C shows the reduced number of surface-connected membrane invaginations (surface connected
h-caveolae, solid white; disconnected h-caveolae, red, cytoplasmicmembrane, translucent white). Scale bar, 100 nm.H and I, the diameter ofN S80E (n

337) and C S80E (n
 178) h-caveolae were analyzed, respectively, at their mid-section. Scale bar, 100 nm. J, quantification revealed a significant loss
of defined h-caveolae formation. Statistical significance was determined by two-tailed t-tests by comparison to the distribution of diameters ofN (p
0.01) and C (p  0.01), respectively.
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ble that the removal of the non-membrane associated
domains (amino acids 1–48) may result in the tighter pack-
ing of caveolin molecules in the membrane, as fluorescence-
based techniques do not show significant differences in the
number of caveolins per vesicle comparing the full-length
and the N construct (data not shown).
Understanding how Cav1 associates with the membrane is
critical for understanding the function of the protein in the
general cellular context. The results presented here demon-
strate a tight association between the OD/CSD and the lipid
bilayer in both mammalian caveolae and our bacterial system.
Our observation that themembrane association of this domain,
and caveola formation, can be disrupted by the insertion of
charged residues at Ser80, Phe81, or Trp85 strongly links caveola
formation to the stable insertion of this domain of caveolin
within the membrane, consistent with a wedge mechanism for
cytoplasmic leaflet expansion and curvature generation (34).
The disruption of OD/CSD membrane association by the
phosphomimetic S80E construct is suggestive of a potential
regulation mechanism for the disassembly of caveolae.
Although no in vivo data suggests Ser80 is directly phosphor-
ylated (for example, see Ref. 49), Cav1 can be phosphorylated
at multiple different residues (50) and several studies have
proposed Ser80 as a potential phosphorylation site (16, 48).
As these mutations increase the availability of the CSD for
protease-mediated degradation and concurrently disrupt
FIGURE 7. The Ser80 to Trp85 region is critical for efficient association of Cav1with the bilayer. A, immuno-EM ofMBP-N-Cav1without the polyhistidine
tag to confirm the potentially charged residues that comprise the C-terminal tag do not effect h-caveola formation, h-caveolae were morphological identical
to h-caveolae from theMBP-N-Cav1-His6 construct. Scale bar
 100 nm. B,N F81E results in heterogeneous h-caveola formation. Scale bar
 100 nm. C,N
W85E pointmutation dramatically effects h-caveolaemorphologywith extensive tubulation of themembrane. Scale bar
 100 nm.D,Western blot of Concav
-caveolin antibody demonstrated reduced abundance of recognition domain in N S80E, N F81E, and N W85E h-caveolae treated with ProK compared
with N and confirms the accessibility of this domain for digestion after the introduction of a glutamate residue. E, quantification of band intensities
comparing  ProK. Band intensities were not significantly reduced with N  ProK, however, N S80E  ProK resulted in a significant reduction in the
abundance of the epitope (p
 0.0003; n
 3). The recognition of this epitope was also significantly reduced in theN F81E andNW85E point mutants (p

0.0007, p
 0.018 respectively; n
 2). Statistical significancewas determined by two-tailed t-tests. F, schematic of Cav1membrane association after introduc-
tion of the negatively charged residue.
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caveola formation, it is possible that the extrusion of this site
from the membrane is a critical step in destabilizing the
caveola unit in response to a mechanical stress (6). This
hypothesis is strengthened by the observation that the S80E
point mutant cannot form caveolae (13) and this region is
masked by the membrane in mature PM-associated caveolae
but exposed after the disruption of caveola structure by cho-
lesterol depletion (47). This region is also exposed in Golgi-
localized caveolin (45).
Although the introduction of charged residues within the
crucial Ser80 to Trp85 region abrogates the formation of
spherical vesicles of regular size and shape (characteristic of
the wild-type caveolin), the mutated caveolin molecule still
induces the formation of tubular elements that show limited
fission from the bacterial cytoplasmic membrane. We have
previously proposed a model in which a polyhedral caveolin
cage is generated through a two-step process, linear exten-
sion and subsequent trimerization of preassembled linear
oligomers (32). This can arise through distinct oligomeric
signals within the membrane-associated region that we now
pinpoint to residues 81–147. An analogy can be made
between the combined activity of epsin (helix insertion) and
FIGURE 8.A library of Cav1mutants reveal the critical domains for h-caveola formation. Immuno-EM of frozen sections of E. coli expressing various Cav1
truncations. A schematic of each truncation is depicted above a representative image of each mutant. Dotted lines represent deleted domains. Red lines are
representative traces of h-caveola morphologies generated by each truncation. A, Cav1-(49–97,134–178); B, Cav1-(49–81,97–178); C, Cav1-(49–134); D,
Cav1-(49–101); E, Cav1-(60–101); F, Cav1-(81–97); G, Cav1-(60–147); H, Cav1-(81–147); I, Cav1-(81–134); J, Cav1-(97–147); K, Cav1-(97–134). Scale bars

100 nm.
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clathrin (cage formation) to the activity of caveolin, which
we propose acts as a hybrid protein with combined mem-
brane insertion and cage assembly properties. We hypothe-
size in wild-type Cav1 the membrane association of the
amphipathic helices of oligomerized CSDs function to pro-
mote vesiculation through destabilization of the membrane,
in a manner similar to the coordinated function of epsin and
clathrin in the internalization of clathrin-coated pits (51).
The mutation of the CSD in the critical Ser80 to Trp85 region
compromises the insertion of these helices, which is
reflected by the protease sensitivity of these mutants. As
such, the extrusion of the CSD from the membrane alters the
membrane remodeling properties of Cav1 resulting in a BAR
domain-like phenotype, greater tubulation, and reduced
membrane fission (51).
These findings have wide reaching implications for the con-
trol of cellular signaling events as the CSD is often presented as
the key binding domain of Cav1. There is a large body of liter-
ature discussing the scaffolding domain and how it potentially
participates in signal regulation via the “caveolin signaling
hypothesis” (2–4, 52–54). This proposes Cav1 mediates signal
regulation through a series of direct protein-protein interac-
tions between binding motifs on signaling proteins and the
CSD, which, in turn facilitates the sequestration of these pro-
teins in inactive forms within caveolae. Our findings argue
against this model and suggest that the CSD is likely to be inac-
cessible for interaction with cytoplasmic proteins as this region
is inaccessible to proteases and antibodies unless caveolamem-
branes are disruptedwith detergents. Althoughdetergent treat-
ment could also potentially affect Cav1-Cav1 interactions that
are dependent on membrane integrity (and thus make this
domain accessible to proteases indirectly) the increased prote-
ase digestion observed upon replacement of Ser80, Phe81, and
Trp85 with glutamate residues argues for the membrane inser-
tion model of this region in the wild-type protein and thus
against direct interactions between the CSD and a caveolin
binding motif on a cytoplasmic protein. Finally, we have char-
acterized the core structural domain for h-caveola formation
and, strikingly, this comprises only 66 amino acids (residues
81–147). The need for tissue-specific delivery of drugs, such as
anti-cancer therapies, is critical to improve the efficacy of treat-
ment and reduce nonspecific deleterious side effects of these
cytotoxic compounds (55). As a tool for biotechnology our pro-
karyotic h-caveolae system is a significant advance on currently
available methods. It is cost effective, easily manufactured, and
purified in a single-step but has the added advantages of being a
genetically encoded nanovesicle that is easily modified for
directed targeting (32). This study has demonstrated significant
reduction in the structural heterogeneity to h-caveolae by the
removal of the soluble N-terminal domain of Cav1, this system
now generates more monodisperse nanovesicles. Further
understanding at the atomic level of how caveolin-lipid inter-
actions allow a 66-amino acid membrane-inserted polypeptide
to generate a uniform nanovesicle should provide insights into
both the fundamental properties of caveolin in forming cave-
olae and elucidate how further modifications can be made to
optimize the properties of genetically encoded nanovesicle.
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